Cellular Synergy
Today we cover $GFOR, $PRCH, $SAGA, and more…

In today’s dish, a clinical-stage biotech company is set to go public through a SPAC. Also, a SPAC signs a letter of intent to take the subsidiaries of a biotech compan…

In today’s dish, a clinical-stage biotech company is set to go public through a SPAC. Also, a SPAC signs a letter of intent to take the subsidiaries of a biotech compan…